Johnson & Johnson's Tremfya Shows Efficacy In Late-Stage Psoriatic Arthritis Study
RFK Jr. to Reinstate 20% of HHS Staff Laid off After DOGE Errors
Argus Research Downgrades Biogen to Hold
Biogen Analyst Ratings
European Stocks Poised for Earnings Surprises in April
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks With Over 4% Dividend Yields